Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Linda G. W. Kerkmeijer"'
Autor:
William A. Hall, Amar U. Kishan, Emma Hall, Himanshu Nagar, Danny Vesprini, Eric Paulson, Uulke A. Van der Heide, Colleen A. F. Lawton, Linda G. W. Kerkmeijer, Alison C. Tree
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionProstate cancer is a common malignancy for which radiation therapy (RT) provides an excellent management option with high rates of control and low toxicity. Historically RT has been given with CT based image guidance. Recently, magnetic r
Externí odkaz:
https://doaj.org/article/43f13186a56a4e30aa6e2988c942c0cf
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/a01ec9c531f44008b03fe5a530f25e60
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
External beam radiotherapy remains the primary treatment modality for localized prostate cancer. The radiobiology of prostate carcinoma lends itself to hypofractionation, with recent studies showing good outcomes with shorter treatment schedules. How
Externí odkaz:
https://doaj.org/article/c261de967ca04070bc6a223b9abe2dfc
Autor:
Marcel A. van Schie, Petra J. van Houdt, Ghazaleh Ghobadi, Floris J. Pos, Iris Walraven, Hans C. J. de Boer, Cornelis A. T. van den Berg, Robert Jan Smeenk, Linda G. W. Kerkmeijer, Uulke A. van der Heide
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Purpose: Quantitative MRI reflects tissue characteristics. As possible changes during radiotherapy may lead to treatment adaptation based on response, we here assessed if such changes during treatment can be detected.Methods and Materials: In the hyp
Externí odkaz:
https://doaj.org/article/72ade8a3936c42c29aadb27823caa4f0
Publikováno v:
Prostate Cancer and Prostatic Diseases, 26, 1, pp. 50-52
Prostate Cancer and Prostatic Diseases, 26, 50-52
Prostate Cancer and Prostatic Diseases, 26, 50-52
Item does not contain fulltext External beam radiotherapy (EBRT) is an important cornerstone in the treatment of localized prostate cancer. Current image-guided radiotherapy (IGRT) techniques allow for more accurate and precise delivery of radiation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf87141136db58b451c08da46e436a8
https://repository.ubn.ru.nl/handle/2066/290707
https://repository.ubn.ru.nl/handle/2066/290707
Publikováno v:
Prostate cancer and prostatic diseases.
External beam radiotherapy (EBRT) is an important cornerstone in the treatment of localized prostate cancer. Current image-guided radiotherapy (IGRT) techniques allow for more accurate and precise delivery of radiation treatment by the use of imaging
Autor:
Linda G W Kerkmeijer, Veda N. Giri, Derya Tilki, Alexander W. Wyatt, Art Rastinehad, Hashim U. Ahmed, Elena Castro, Alexandre de la Taille, Stacy Loeb, Shusuke Akamatsu, Giovanni Lughezzani, Maria J. Ribal, Peter C. Black, Caroline M. Moore, Neal D. Shore, Matthew R. Cooperberg, Rafael Sanchez-Salas, Yaw A. Nyame, Martin E. Gleave, Simon Tanguay
Publikováno v:
Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting May 21–22, 2021. 2:S30-S50
Autor:
Martin Gotthardt, J. Fred Verzijlbergen, Jean-Paul A. van Basten, Melline G.M. Schilham, James Nagarajah, Robert Jan Smeenk, Sandra Heskamp, J. Alfred Witjes, Steffie M. B. Peters, Tom W. J. Scheenen, Marcel J.R. Janssen, Inge M. van Oort, Maike J. M. Uijen, Jelle O. Barentsz, Niven Mehra, Michiel Sedelaar, Bastiaan M. Privé, Diederik M. Somford, Constantijn H.J. Muselaers, Annemarie Eek, Winald R. Gerritsen, Linda G W Kerkmeijer, Mark Konijnenberg, Patrik Zamecnik
Publikováno v:
Clinical Cancer Research, 27, 13, pp. 3595-3601
Clinical Cancer Research, 27, 3595-3601
Clinical Cancer Research, 27(13), 3595-3601. American Association for Cancer Research Inc.
Clinical Cancer Research, 27, 3595-3601
Clinical Cancer Research, 27(13), 3595-3601. American Association for Cancer Research Inc.
Purpose: [177Lu]Lu-PSMA-617 radioligand therapy (177Lu-PSMA) is a novel treatment for metastatic castration-resistant prostate cancer (mCRPC), which could also be applied to patients with metastatic hormone-sensitive prostate cancer (mHSPC) with PSMA
Autor:
Sofie Isebaert, Robert Jan Smeenk, M. Kunze-Busch, Evelyn M. Monninkhof, V. Groen, K. Haustermans, Nicolaas P.A. Zuithoff, Helena M. Verkooijen, Floris J. Pos, M. Van Schie, J. Van der Voort van Zijp, J. de Boer, U.A. Van der Heide, Cédric Draulans, Linda G W Kerkmeijer
Publikováno v:
Radiotherapy and Oncology. 161:S393-S395
Autor:
Marloes van der Leest, Gilles Defraene, Linda G W Kerkmeijer, Sofie Isebaert, Robert Jan Smeenk, Raymond Oyen, Uulke A. van der Heide, Steven Joniau, Frederik Maes, Wouter V. Vogel, Robin De Roover, Karolien Goffin, Cindy Mai, Cédric Draulans, M. Kunze-Busch, Karin Haustermans, Marcel J.R. Janssen, Floris J. Pos, Patrik Zamecnik, Stijn W.T.P.J. Heijmink, James Nagarajah
Publikováno v:
Practical Radiation Oncology, 11, 202-211
Practical Radiation Oncology, 11, 3, pp. 202-211
Practical Radiation Oncology, 11, 3, pp. 202-211
PURPOSE: To assess the intermodality and intertracer variability of gallium-68 (68Ga)- or fluorine-18 (18F)-labeled prostate-specific membrane antigen (PSMA) positron emission tomography (PET) and biparametric magnetic resonance imaging (bpMRI)-based